Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of Two Oral Formulations of LX4211 in Patients With Type 2 Diabetes Mellitus

This study has been completed.
Information provided by:
Lexicon Pharmaceuticals Identifier:
First received: August 24, 2010
Last updated: March 29, 2011
Last verified: March 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: October 2010 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):